172 related articles for article (PubMed ID: 10632083)
1. Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.
Zhao XH; Sun XY; Bergdahl A; Edvinsson L; Hedner T
J Pharm Pharmacol; 1999 Nov; 51(11):1257-65. PubMed ID: 10632083
[TBL] [Abstract][Full Text] [Related]
2. Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
Zhao XH; Sun XY; Edvinsson L; Hedner T
J Hypertens; 1997 Jan; 15(1):19-27. PubMed ID: 9050966
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
4. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Gicquiaux H; Tschöpl M; Doods HN; Bucher B
Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
Malmstrom RE; Lundberg JM
Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
7. Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure.
Bergdahl A; Nilsson T; Sun XY; Hedner T; Edvinsson L
Eur J Pharmacol; 1998 Nov; 360(2-3):165-73. PubMed ID: 9851583
[TBL] [Abstract][Full Text] [Related]
8. The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure.
Zhang W; Lundberg JM; Thorén P
Life Sci; 1999; 65(17):1839-44. PubMed ID: 10576563
[TBL] [Abstract][Full Text] [Related]
9. The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304.
Capurro D; Huidobro-Toro JP
Eur J Pharmacol; 1999 Jul; 376(3):251-5. PubMed ID: 10448884
[TBL] [Abstract][Full Text] [Related]
10. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP
J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
Duckles SP; Adner M; Edvinsson L; Krause DN
Eur J Pharmacol; 1997 Dec; 340(1):75-9. PubMed ID: 9527509
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
14. Decreased responsiveness of vascular postjunctional alpha1-, alpha2-adrenoceptors and neuropeptide Y1 receptors in rats with heart failure.
Feng Q; Sun X; Lu X; Edvinsson L; Hedner T
Acta Physiol Scand; 1999 Aug; 166(4):285-91. PubMed ID: 10468665
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.
Bergdahl A; Nilsson T; Cantera L; Nilsson L; Sun XY; Hedner T; Erlinge D; Valdemarson S; Edvinsson L
Eur J Pharmacol; 1996 Nov; 316(1):59-64. PubMed ID: 8982651
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Chen SH; Cheung RT
Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y selectively potentiates alpha1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery.
Tsurumaki T; Honglan P; Higuchi H
J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S33-7. PubMed ID: 14871026
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 receptor antagonist (BIBP 3226) attenuates stress evoked tachycardia in conscious spontaneously hypertensive rats.
Zhang W; Lundberg JM; Thorén P
Cardiovasc Drugs Ther; 1997 Dec; 11(6):801-6. PubMed ID: 9512876
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.
Racchi H; Schliem AJ; Donoso MV; Rahmer A; Zúñiga A; Guzmán S; Rudolf K; Huidobro-Toro JP
Eur J Pharmacol; 1997 Jun; 329(1):79-83. PubMed ID: 9218687
[TBL] [Abstract][Full Text] [Related]
20. Cardiac function in neuropeptide Y Y4 receptor-knockout mice.
Smith-White MA; Herzog H; Potter EK
Regul Pept; 2002 Dec; 110(1):47-54. PubMed ID: 12468109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
